FACE-selective fluorogenic cycloaddition reaction between coumarin azides and sugar terminal alkynes: an experimental and computational study
摘要:
Copper catalyzed azide-alkyne cycloaddition reaction (CuAAC) of non-fluorescent coumarin azides and sugar terminal alkynes afforded intense fluorescent 1,2,3-triazoles in 75-85% of yield. The photophysical properties of coumarin-sugar triazoles influenced greatly, upon introducing different substituents at 6th and 7th positions. The experimental observations were further supported by TD-DFT computational studies. (C) 2011 Elsevier Ltd. All rights reserved.
FACE-selective fluorogenic cycloaddition reaction between coumarin azides and sugar terminal alkynes: an experimental and computational study
摘要:
Copper catalyzed azide-alkyne cycloaddition reaction (CuAAC) of non-fluorescent coumarin azides and sugar terminal alkynes afforded intense fluorescent 1,2,3-triazoles in 75-85% of yield. The photophysical properties of coumarin-sugar triazoles influenced greatly, upon introducing different substituents at 6th and 7th positions. The experimental observations were further supported by TD-DFT computational studies. (C) 2011 Elsevier Ltd. All rights reserved.
Synthesis of quinoline coupled [1,2,3]-triazoles as a promising class of anti-tuberculosis agents
作者:K. Karthik Kumar、S. Prabu Seenivasan、Vanaja Kumar、T. Mohan Das
DOI:10.1016/j.carres.2011.06.028
日期:2011.10
A series of quinoline coupled 1,2,3-triazoles compounds have been synthesized by 'click chemistry' from azidomethyl quinoline with different alkynes. The efficiency and fidelity of the Cu(I)-catalyzed azide-alkyne reaction are substantiated by good yields and exclusive formation of the expected 1,4-disubstituted triazole product. All the synthesized compounds were screened for anti-tubercular activity
通过“点击化学”从叠氮甲基喹啉与不同炔烃中合成了一系列喹啉偶联的1,2,3-三唑化合物。Cu(I)催化的叠氮化物-炔烃反应的效率和保真度通过良好的收率和预期的1,4-二取代的三唑产物的排他性得以证实。通过荧光素酶报道噬菌体(LRP)测定,筛选所有合成的化合物针对结核分枝杆菌H37Rv的抗结核活性。喹啉偶联三唑糖杂化物20是该系列中最有效的化合物,根据相对光单位在5和25 cup / mL时的减少百分比计算,减少量分别为76.41%和78.37%。